These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method. Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F Platelets; 2011; 22(5):321-7. PubMed ID: 21526886 [TBL] [Abstract][Full Text] [Related]
24. Overproduction of antiplatelet antibody against glycoprotein IIb after splenectomy in a patient with Evans syndrome resulting in acquired thrombasthenia. Fuse I; Higuchi W; Narita M; Watanabe T; Hattori A; Aizawa Y Acta Haematol; 1998; 99(2):83-8. PubMed ID: 9554455 [TBL] [Abstract][Full Text] [Related]
25. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran. Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132 [TBL] [Abstract][Full Text] [Related]
26. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Bettaieb A; Oksenhendler E; Duedari N; Bierling P Clin Exp Immunol; 1996 Jan; 103(1):19-23. PubMed ID: 8565280 [TBL] [Abstract][Full Text] [Related]
27. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk? Léticée N; Kaplan C; Lémery D Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry. Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026 [TBL] [Abstract][Full Text] [Related]
29. [Glanzmann's thrombasthenia: a rare example of an integrin deficit]. Perutelli P; Mori PG Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042 [TBL] [Abstract][Full Text] [Related]
30. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. Kuwana M; Okazaki Y; Kaburaki J; Kawakami Y; Ikeda Y J Immunol; 2002 Apr; 168(7):3675-82. PubMed ID: 11907134 [TBL] [Abstract][Full Text] [Related]
31. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa. Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089 [TBL] [Abstract][Full Text] [Related]
33. Serum from patients with chronic idiopathic thrombocytopenic purpura frequently affect the platelet function. Olsson A; Andersson PO; Tengborn L; Wadenvik H Thromb Res; 2002 Aug; 107(3-4):135-9. PubMed ID: 12431479 [TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization. Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707 [TBL] [Abstract][Full Text] [Related]
35. Triple jeopardy: A case of Glanzmann's thrombasthenia with anti-GPIIb-IIIa antibodies and HPA incompatibility resulting in stillbirth. Soni P; Mantri S; Prabhudesai A; Patil R; Shanmukhaiah C; Shetty S Thromb Res; 2019 Sep; 181():141-144. PubMed ID: 31404847 [No Abstract] [Full Text] [Related]
36. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. Chan H; Moore JC; Finch CN; Warkentin TE; Kelton JG Br J Haematol; 2003 Sep; 122(5):818-24. PubMed ID: 12930395 [TBL] [Abstract][Full Text] [Related]
37. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia. Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137 [TBL] [Abstract][Full Text] [Related]
38. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004 [TBL] [Abstract][Full Text] [Related]
39. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383 [TBL] [Abstract][Full Text] [Related]
40. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia. Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M Nephron; 1994; 68(4):442-8. PubMed ID: 7870229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]